In treated samples (with TLR7/8 agonist), mTOR expression median (IQR) values were 0.31 (0.16–1.04) in CLL group and 0.49 (0.34–0.73) in Normal group with o statistically significant difference (p = 0.479). The gene discussed is TLR7; the disease is B-cell chronic lymphocytic leukemia.